Ambrisentan

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51433200
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51433201

This classification denotes an endothelin-1 protein receptor antagonist and antihypertensive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HW6NV07QEC. European Medicines Agency schedules Ambrisentan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25424. Ambrisentan generally arises in the molecular formula C22H22N2O4. The term AMBRISENTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations schedule ambrisentan under HS 29335995 and SITC 51576. As of Q4 2014, AMBRISENTAN remains the US FDA Preferred Term for this commodity. Ambrisentan bears US NLM identifiers UMLS ID C1176329 and NCI Concept Code C72694. SMILES: O(C(C(Oc1nc(cc(n1)C)C)C(=O)O)(c1ccccc1)c1ccccc1)C.

Same parent

Under 51433200 · 2

51433201 Ambrisentan You are here 51433202 Darusentan Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51430000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.